Mckinley Capital Management LLC Ultragenyx Pharmaceutical Inc. Put Options Transaction History
Mckinley Capital Management LLC
- $809 Million
- Q1 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding RARE
# of Institutions
292Shares Held
78.8MCall Options Held
570KPut Options Held
228K-
Vanguard Group Inc Valley Forge, PA8.7MShares$389 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.09MShares$317 Million5.31% of portfolio
-
Black Rock Inc. New York, NY5.24MShares$234 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.1MShares$183 Million0.03% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.86MShares$173 Million0.53% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.13B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...